Literature DB >> 8332574

The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis.

A Bohle1, M Wehrmann, R Eissele, H von Gise, S Mackensen-Haen, C Müller.   

Abstract

Investigation of the long-term prognosis and pathogenesis of chronic renal failure in 225 cases of AA and AL renal amyloidosis (perireticular and perireticular + pericollagenous amyloidosis) yielded the following results: 1) The prognosis of both AA and AL amyloidosis is poor, and is worse than all other types of glomerulopathy with the exception of rapidly progressive glomerulonephritis. 2) The probability of maintaining renal function in AL amyloidosis is no lower than that in AA amyloidosis. 3) The prognosis of both AA and AL amyloidosis is significantly worse in cases in which the renal cortical interstitium exhibits fibrosis at the time of the biopsy than in those in which it is normal. 4) In AA and AL amyloidosis, as in various types of inflammatory glomerulopathy, the relative area of the renal cortical interstitium shows a significant positive correlation with the serum creatinine concentration and a significant negative correlation with the creatinine clearance. However, the extent of interstitial amyloid deposition does not correlate with the serum creatinine concentration. Deposition of amyloid in the renal cortical interstitium has no effect on renal excretory function. 5) The long-term prognosis of renal amyloidosis is related to the severity of the glomerular amyloidosis in as much as it is generally worse in Grades III to V than in Grades I and II. However, it must be borne in mind that the incidence of interstitial fibrosis, which is decisive for the long-term prognosis, increases with the severity of glomerular changes. 6) The long-term prognosis of renal amyloidosis is worse if acute renal failure or interstitial fibrosis is present at the time of the biopsy. Patients with both acute renal failure and interstitial fibrosis have the worst prognosis. 7) Isolated glomerular amyloidosis, even if there is severe vascular amyloidosis (vas afferns), does not lead to renal insufficiency or even to a rise in serum creatinine concentration. 8) The number of T lymphocytes in the tubular epithelium in AA and AL amyloidosis is significantly greater than normal, and the number of T lymphocytes, macrophages/monocytes, and fibroblasts/fibrocytes per unit area of interstitium is also significantly increased. 9) As far as the pathogenesis of renal cortical interstitial fibrosis in renal amyloidosis is concerned, it is proposed that, in some cases, this develops from the interstitial edema that is seen in biopsy specimens of patients with renal amyloidosis and acute renal failure.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8332574     DOI: 10.1016/s0344-0338(11)80516-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  Association between clinical characteristics and AL amyloid deposition in the kidney.

Authors:  Mitsuyo Itabashi; Takashi Takei; Misao Tsukada; Hidekazu Sugiura; Keiko Uchida; Ken Tsuchiya; Kazuho Honda; Kosaku Nitta
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Using digital whole-slide images to evaluate renal amyloid deposition and its association with clinical features and outcomes of AL amyloidosis.

Authors:  Yun Fan; Dandan Liang; Haochen Rui; Feng Xu; Yuanyuan Xia; Fan Yang; Shaoshan Liang; Xiaodong Zhu; Mingchao Zhang; Xianghua Huang; Caihong Zeng
Journal:  J Nephrol       Date:  2021-03-02       Impact factor: 3.902

3.  Renal amyloidosis: validation of a proposed histological scoring system in an independent cohort.

Authors:  Joris J Hoelbeek; Jesper Kers; Eric J Steenbergen; Joris J T H Roelofs; Sandrine Florquin
Journal:  Clin Kidney J       Date:  2020-03-24

4.  Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.

Authors:  Hakki Yilmaz; Osman Inan; Tahir Darcin; Mukadder Ayse Bilgic; Ali Akcay
Journal:  Clin Exp Nephrol       Date:  2014-07-25       Impact factor: 2.801

5.  Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever.

Authors:  Ayşe Oner; Ozlem Erdoğan; Gülay Demircin; Mehmet Bülbül; Leyla Memiş
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

Review 6.  New advances in renal amyloidosis.

Authors:  Shinichi Nishi; Bassam Alchi; Nofumi Imai; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

Review 7.  Amyloid in surgical pathology.

Authors:  Christoph Röcken; Knut Sletten
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

Review 8.  Renal amyloidosis in children.

Authors:  Yelda Bilginer; Tekin Akpolat; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2011-03-01       Impact factor: 3.714

9.  Correlation between amyloid deposits affecting renal compartments and glomerular filtration rate during renal biopsy in a renal amyloidosis case series.

Authors:  E O Fonseca; M L R Caldas; P J Soares Filho; J R Almeida
Journal:  Braz J Med Biol Res       Date:  2020-05-18       Impact factor: 2.590

10.  Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis.

Authors:  Takeshi Kuroda; Naohito Tanabe; Daisuke Kobayashi; Yoko Wada; Shuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  BMC Nephrol       Date:  2012-09-24       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.